Monday, March 04, 2013 10:43:59 PM
All very true. However in the US, there is NO OTC Ibuprofen gel available and this would be the first of its kind - question is which Antares delivery system will be used.
Tappy mentioned the clinical trials capital expense by PFE as $30 million. I have also heard the same number (from an unnamed, reliable, double secret undisclosed source). I'm curious as to what that could translate to, as far as fees for a partner. Albeit, as biopete noted, Antares is not doing the heavy lifting, but their delivery technology is behind it - or to put it another way, making it possible.
Also, shadowplay mentioned something that I've thought about as well, and that's the "end" of the known agreement language of 3yrs post launch. What happens after that? This could be a two tranche agreement in the wings, a renegotiation when sales, etc are determinable. The first tranche, we know exists. Is there a second? Entirely possible. Or if not, then given the 3 yr lifespan, what's the size of the final payment upon successful conclusion to compensate Antares for use of their delivery system for infinity?
jab9
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM